User Experience with a New Smartphone Application for Blood Glucose Monitoring (BGM) in an Information-Motivation-Behavioral Skills (IMB) Model Study

Abstract

The CONTOUR®NEXT ONE BGM system (BGMS) includes a wireless-enabled BG meter that links to the CONTOUR®Diabetes app installed on a mobile device. The system, based on the IMB model, detects and reports patterns of BG readings and provides guidance for self-management. The IMB model emphasizes the need for actionable information, motivation to act, and behavioral skills for acting effectively, to strengthen self-management of diabetes. This 6-week study with 46 insulin-using individuals with diabetes assessed the BGMS with the CONTOUR®Diabetes app Version 2 Prototype. Participant appraisal of the BGM/app system was positive on multiple dimensions (Table 1). Participants strongly agreed/agreed that using this BGM/app system provided them with a better understanding of their disease (98%), helped them feel more engaged with their diabetes management program (91%), they felt more motivated to adhere to their health care provider's therapy and testing recommendations (76%), that the “My Patterns” pattern recognition feature was helpful in managing their diabetes (73%), and that they found themselves testing more frequently throughout the day (56%). Disclosure W. Fisher: Consultant; Self; Bayer AG, Ascensia Diabetes Care, Roche Diabetes Care Health and Digital Solutions. A. Stuhr: Employee; Self; Ascensia Diabetes Care. J. Wallace: Employee; Self; Ascensia Diabetes Care. S. Zhuplatov: Employee; Self; Ascensia Diabetes Care. T.S. Bailey: Research Support; Self; Abbott. Consultant; Self; Abbott. Speaker's Bureau; Self; Abbott. Research Support; Self; Ambra BioScience, Ascensia Diabetes Care, Becton, Dickinson and Company. Consultant; Self; Becton, Dickinson and Company. Research Support; Self; Boehringer Ingelheim Pharmaceuticals, Inc., Calibra Medical. Consultant; Self; Calibra Medical. Research Support; Self; Companion Medical, Dexcom, Inc., Glooko, Inc., GlySens Incorporated, Lexicon Pharmaceuticals, Inc., Eli Lilly and Company. Consultant; Self; Eli Lilly and Company. Speaker's Bureau; Self; Eli Lilly and Company. Research Support; Self; Medtronic MiniMed, Inc.. Consultant; Self; Medtronic MiniMed, Inc.. Speaker's Bureau; Self; Medtronic MiniMed, Inc.. Research Support; Self; Novo Nordisk Inc.. Consultant; Self; Novo Nordisk Inc.. Speaker's Bureau; Self; Novo Nordisk Inc.. Research Support; Self; Sanofi. Consultant; Self; Sanofi. Speaker's Bureau; Self; Sanofi. Research Support; Self; Senseonics. Consultant; Self; Intarcia Therapeutics, Inc.. Research Support; Self; Versartis, Inc., Xeris Pharmaceuticals, Inc., MannKind Corporation. S. Pardo: Employee; Self; Ascensia Diabetes Care.